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Abstract
N-acetylcysteine (NAC; antioxidant and thiol donor) supplementation has
improved exercise performance and delayed fatigue, but the underlying mech-
anisms are unknown. One possibility is NAC supplementation increases limb
blood flow during severe-intensity exercise. The purpose was to determine if
NAC supplementation affected exercising arm blood flow and muscle oxy-
genation characteristics. We hypothesized that NAC would lead to higher limb
blood flow and lower muscle deoxygenation characteristics during severe-
intensity exercise. Eight healthy nonendurance trained men (21.8  1.2 years)
were recruited and completed two constant power handgrip exercise tests at
80% peak power until exhaustion. Subjects orally consumed either placebo
(PLA) or NAC (70 mg/kg) 60 min prior to handgrip exercise. Immediately
prior to exercise, venous blood samples were collected for determination of
plasma redox balance. Brachial artery blood flow (BABF) was measured via
Doppler ultrasound and flexor digitorum superficialis oxygenation characteris-
tics were measured via near-infrared spectroscopy. Following NAC supple-
mentaiton, plasma cysteine (NAC: 47.2  20.3 lmol/L vs. PLA:
9.6  1.2 lmol/L; P = 0.001) and total cysteine (NAC: 156.2  33.9 lmol/L
vs. PLA: 132.2  16.3 lmol/L; P = 0.048) increased. Time to exhaustion was
not significantly different (P = 0.55) between NAC (473.0  62.1 sec) and
PLA (438.7  58.1 sec). Resting BABF was not different (P = 0.79) with NAC
(99.3  31.1 mL/min) and PLA (108.3  46.0 mL/min). BABF was not dif-
ferent (P = 0.42) during exercise or at end-exercise (NAC: 413  109 mL/
min; PLA: 445  147 mL/min). Deoxy-[hemoglobin+myoglobin] and total-
[hemoglobin+myoglobin] were not significantly different (P = 0.73 and
P = 0.54, respectively) at rest or during exercise between conditions. We con-
clude that acute NAC supplementation does not alter oxygen delivery during
exercise in men.
Introduction
The production of free radicals occurs at rest (Richardson
et al. 2007; Bailey et al. 2007) and increases during exer-
cise (Richardson et al. 2007; Bailey et al. 2003, 2004,
2007). Although endogenous antioxidant systems (e.g.,
superoxide dismutase, catalase, glutathione peroxidase)
help minimize the increase in free radicals (Sen 1995), the
accumulation of free radicals occurs with exercise
(Richardson et al. 2007; Bailey et al. 2003, 2004, 2007),
which affects processes associated with muscular fatigue
(Reid 2015). In 1990, N -acetylcysteine (NAC), an antiox-
idant and thiol donor, was shown to delay fatigue in rab-
bit diaphragm fibers (Shindoh et al. 1990). Since then,
NAC supplementation has been reported to delay fatigue
and/or improve exercise performance with small muscle
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mass (Reid et al. 1994; Supinski et al. 1997; Travaline
et al. 1997; Matuszczak et al. 2005; Kelly et al. 2009;
Smith et al. 2014), and large muscle mass exercise (Corn
and Barstow 2011; Medved et al. 2004b; McKenna et al.
2006; Slattery et al. 2014; Cobley et al. 2011). However,
this is not a consistent finding in large muscle mass exer-
cise (Medved et al. 2003, 2004a; Bailey et al. 2011; Trewin
et al. 2013), with some studies reporting high intersubject
variability (Bailey et al. 2011; Medved et al. 2004a).
Although results may be conflicting, mechanistically,
NAC has been reported to positively affect Na+-K+
ATPase pump activity (McKenna et al. 2006) and regula-
tion of calcium release within the myofibril (Andrade
et al. 2001).
It has been speculated that NAC may have positive car-
diovascular affects (Reid et al. 1994; Slattery et al. 2014;
Reid 2015), which may also contribute to delay exercise-
induced fatigue. NAC has been suggested to augment the
effects of nitric oxide (Simon et al. 1993) and increase
flow-mediated dilation using bovine vascular rings
(Cooke et al. 1990). These data suggest NAC supplemen-
tation may lead to greater nitric oxide bioavailability and
exercise-induced vasodilation.
During low-intensity exercise, free radicals contribute
to vasodilation via vasoactive properties (Richardson et al.
2007; Liu et al. 2003). Therefore, it remains unlikely NAC
supplementation would lead to increased blood flow dur-
ing low-intensity exercise. In support, NAC supplementa-
tion does not alter limb blood flow at rest (Smith et al.
2014; Nyberg et al. 2012) nor during moderate-intensity
knee extension exercise (Nyberg et al. 2012) despite
reducing venous oxidized glutathione in healthy young
men (Nyberg et al. 2014). In contrast, higher exercise
intensities lead to greater free radical production (Bailey
et al. 2004, 2003), which can attenuate nitric oxide (NO)
bioavailability (Thomas et al. 2006) and exercise-induced
vasodilation. Therefore, NAC may lead to greater vasodi-
lation and increased blood flow during severe-intensity
exercise. During severe-intensity cycling exercise, NAC
supplementation did not increase plasma nitrite levels
compared to placebo (Bailey et al. 2011), but locomotor
muscle blood flow was not directly measured. In this
study, we chose small muscle mass exercise (i.e., hand-
grip) because previous studies have consistently found
improvements in small muscle mass exercise performance
with NAC (Ferreira and Reid 2008). We were also inter-
ested in determining if NAC influences muscle oxygena-
tion characteristics because antioxidant supplementation
has recently been shown to lower microvascular oxygena-
tion at rest and during muscle contractions (Copp et al.
2009). It is currently unclear if NAC supplementation
affects oxygen delivery during severe-intensity exercise
which could be a mechanism as to how NAC improves
exercise performance. The purpose of the study, therefore,
was to determine if NAC supplementation influenced
exercising limb blood flow and muscle oxygenation char-
acteristics during severe-intensity handgrip exercise to
fatigue in healthy men. We hypothesized that acute oral
NAC supplementation would increase limb blood flow
and lower muscle deoxygenation during severe-intensity
exercise.
Methods
Eight healthy, nonendurance trained men were recruited
as subjects and participated in this study (age:
21.8  1.2 years; height: 174.9  9.3 cm; weight:
77.1  17.5 kg; peak power: 6.0  1.3 W). Each subject
provided written consent and medical health history prior
to testing. All subjects were free of chronic and/or acute
cardiovascular and metabolic diseases. Subjects refrained
from antioxidant supplementation for at least 1 week
prior to and over the course of the study. Subjects
abstained from vigorous physical activity for 12 h and
food and caffeine ingestion for 4 h prior to testing. All
experimental procedures were approved by the Institu-
tional Review Board at Kansas State University, Manhat-
tan, KS and conformed to the Declaration of Helsinki.
Experimental design
This study was a randomized double-blind placebo con-
trolled cross-over design. Subjects reported to the labora-
tory on four different occasions. First, subjects performed
an incremental handgrip test to determine peak power
(Ppeak). On the second visit, subjects performed a famil-
iarization trial of handgrip exercise at 80% Ppeak to
exhaustion. The third and fourth visits were randomized
with a washout time of at least 1 week (Reid et al. 1994;
Kelly et al. 2009). One hour prior to handgrip exercise,
subjects orally consumed 70 mg/kg of either NAC or pla-
cebo (PLA) consisting of cellulose. One hour following
NAC or PLA ingestion and immediately prior to handgrip
exercise, a venous blood sample was taken from the ante-
cubital vein for plasma redox analyses. Then, subjects per-
formed handgrip exercise at 80% Ppeak to exhaustion.
NAC Supplementation
NAC and PLA (cellulose) pills (600 mg per pill) were
used for oral administration. The NAC and PLA pills
were similar in size, shape, and color. One investigator
prepared the pills and performed the randomization for
the entire study and was not present for data collection.
Investigators and subjects were blinded to the pills during
data collection. In this study, an acute oral dosage of
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70 mg/kg of NAC and PLA was consumed 1 hr prior to
handgrip exercise. This NAC dosage was used because it
was reported to increase plasma total cysteine, cysteine,
and decrease oxidized glutathione with no adverse reac-
tions (Ferreira et al. 2011). Because whole pills were
administered for each subject, the number of pills admin-
istered was matched to equal 70 mg/kg as closely as possi-
ble. Consumption of NAC supplementation 1 hr prior
was used because plasma NAC and cysteine have been
reported to peak within 60–120 min of ingestion (Borg-
strom and Kagedal 1990).
Handgrip ergometer
A custom built handgrip ergometer was used for all exer-
cise testing as previously described (Broxterman et al.
2014). When the subjects were seated at the handgrip
ergometer and placed their hands on the handrail, their
forearms were at heart level and elbows were slightly bent.
The contraction frequency was 20 contractions per min
with a 50% duty cycle. Correct timing was ensured with
an audio recording set with the specific timing of the
duty cycle and feedback provided by the investigator
monitoring the tests. For the incremental handgrip test,
the test started at 1.0 W and power output was increased
0.5 W each minute until exhaustion. The Ppeak was the
highest power output attained by the subjects for which
at least 30 sec of the stage was completed. For the sub-
maximal handgrip tests, subjects completed constant
power (80% Ppeak) tests to exhaustion. This handgrip
protocol (contraction frequency, duty cycle, and intensity)
has recently been shown to lead to the development of
peripheral muscle fatigue (Broxterman et al. 2015).
Doppler ultrasound
Brachial artery blood velocity was measured via Doppler
ultrasound (Vivid 3; GE Medical Systems, Milwaukee,
WI). The gate of the Doppler was set to full width of the
brachial artery to ensure complete insonation. All Dop-
pler velocity measurements were corrected for the angle
of insonation, which was adjusted to be less than 60
degrees. Measurements in the brachial artery were made
2–5 cm above the antecubital fossa. Mean blood velocity
( _Vmean; cm 9 sec
1) was defined as time averaged mean
velocity over each 3 s contraction cycle. All ( _Vmean were
determined over the last three contraction cycles of each
min and at end-exercise. Brachial artery blood flow
(BABF) was calculated as the product of _Vmean and vessel
cross-sectional area (CSA). Brachial artery diameters were
measured in the transverse axis using two-dimensional
sonography and used to calculate vessel CSA (CSA = Πr2;
cm2). Brachial artery diameters were measured at rest and
each min of exercise. Brachial artery diameters were mea-
sured by the same investigator who was blinded to the
condition. Shear rate was defined as 4( _VmeanD1), where
D is diameter in centimeters.
Near-infrared spectroscopy
A frequency-domain multi-distance Near-infrared spec-
troscopy (NIRS) system (Oxiplex TS, ISS, Champaign, IL)
was used to determine the oxygenation characteristics of
the flexor digitorum superficialis. Briefly, this NIRS device
consists of eight light-emitting diodes (LED) operating at
wavelengths of 690 and 830 nm with four LEDs per
wavelength and with one detector fiber bundle and LED-
detector separation distances of 2.0, 2.5, 3.0, and 3.5 cm.
Electromyography and palpation was used to locate the
flexor digitorum superficialis on the right arm and
the NIRS probe was securely placed longitudinally along
the belly of the muscle. Next, the probe placement was
marked with indelible ink for reproducible placement.
The NIRS probe was calibrated prior to each test using a
calibration block with known scattering coefficients and
absorption and calibration was confirmed on a separate
block with different absorption and scattering coefficients.
The NIRS data were collected at 50 Hz and stored for
post hoc analysis. The NIRS data were processed using 3
s averages and three consecutive contraction cycles at the
end of each minute were averaged. The deoxy-[hemoglo-
bin+myoglobin] (deoxy-[Hb+Mb]) is relatively insensitive
to changes in blood volume (De Blasi et al. 1993; Ferrari
et al. 1997; Grassi et al. 2003) and has been used to esti-
mate fractional oxygen extraction (De Blasi et al. 1994;
Ferrari et al. 1997; Grassi et al. 2003). The NRIS device
used provides absolute concentrations (lmol/L) for
deoxy-[Hb+Mb] and oxygenated-[hemoglobin+myoglo-
bin] (oxygenated-[Hb+Mb]), which sum to determine
total-[hemoglobin+myoglobin] (total-[Hb+Mb]), as well
as a tissue oxygenation index (TOI; %Saturation of [he-
moglobin+myglobin]). Dynamic reduced scattering coeffi-
cients were measured and incorporated in all of the NIRS
data calculations.
Blood analysis
One hr following the acute oral consumption of NAC
and PLA 2–5 mL of venous blood were slowly drawn
from the antecubital vein. If the samples were hemolyzed,
they were discarded and an additional venous blood draw
was performed. The venous blood sample was added to a
microcentrifuge tube containing a preservative solution
(2 mg iodoacetic acid, 1 mg bathophenanthroline disul-
fonate, and 100 mmol/L serine-borate (pH 8.5) contain-
ing 0.5 mg sodium heparin) and inverted gently. The
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microcentrifuge tube was centrifuged (29,905 g, 30 sec)
and then 200 lL of supernatant was added to a tube con-
taining 200 lL of perchloric acid solution and stored at
60°C for later analysis. High performance liquid chro-
matography was used to analyze the plasma samples for
glutathione (GSH), oxidized glutathione (GSSG), cysteine
(CySH), cystine (CySS), and cysteine-glutathione disulfide
(CySSG) (Clinical Biomarkers Laboratory, Emory
University, Atlanta, GA) as previously done (Ferreira
et al. 2011). Total glutathione (tGSH) was calculated as
GSH + 2GSSG + CySSG. Total cysteine (tCyS) was cal-
culated as CySH + 2CySS + CySSG.
Statistical analysis
Sigma Statistical (Jandel Scientific Software, Chicago, IL)
was used for data analysis. Data are presented as
mean  SD. Normality of the data was confirmed using
Shapiro–Wilk normality tests. Paired t-tests were used to
determine differences in time to exhaustion, preexercise
plasma redox values, and absolute changes in diameter,
blood flow and shear rate (end-exercise minus resting)
between conditions. Differences in cardiovascular vari-
ables and muscle oxygenation characteristics were deter-
mined by a 2 9 2 (group 9 time) repeated measures
analysis of variance (ANOVA) and the F statistics (F)
were reported. A Tukey’s post hoc analysis was per-
formed to determine where significant differences
existed. Statistical significance was set at P < 0.05 for all
analyses.
Results
NAC supplementation
The NAC group orally consumed ~67 mg/kg and
reported no gastrointestinal distress. Figure 1 shows
preexercise CySH, CySS, and CySH:tCyS following
NAC and PLA supplementation. Following NAC
supplementation, CySH (NAC: 47.2  20.3 lmol/L vs.
PLA: 9.6  1.2 lmol/L; P = 0.001), tCyS (NAC:
156.2  33.9 lmol/L vs. PLA: 132.2  16.3 lmol/L;
P = 0.048), GSSG (NAC: 0.18  0.08 lmol/L vs.
PLA: 0.04  0.02 lmol/L; P < 0.001), tGSH (NAC:
6.2  1.0 lmol/L vs. PLA: 4.7  1.4 lmol/L; P = 0.027),
and CySH/tCyS (NAC: 0.30  0.07 lmol/L vs. PLA:
0.07  0.01 lmol/L; P < 0.001) were significantly higher
and GSH/GSSG was lower (NAC: 22.9  9.2 lmol/L vs.
PLA: 76.8  17.6 lmol/L; P < 0.001) compared to PLA.
Following NAC supplementation, the increased CySH,
GSSG, and CySH:tCyS occurred in all eight subjects,
while the increases in tCyS and tGSH occurred in six of
eight subjects.
Time to exhaustion
Figure 2 shows the mean and individual time to exhaus-
tion for NAC and PLA. Time to exhaustion was not dif-
ferent between NAC and PLA (NAC: 473.0  62.1 sec vs.
PLA NAC
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Figure 1. Plasma cysteine derivatives with NAC and PLA. Individual
(closed circles) and mean (open circles) preexercise plasma CySH
(A), CySS (B), and CySH:tCyS (C) following NAC and PLA
supplementation. NAC supplementation led to significant increases
CySH and CySH:tCyS. NAC, N-acetylcysteine;pla, placebo;CySH,
cysteine; CySS, Cystine; tCyS, Total cysteine; tGSH, Total
glutathione.
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PLA: 438.7  58.1 sec; P = 0.55). There was inherent
intersubject variability with five subjects showing
improved performance (+3%, +49%, +27%, +81%, +5%)
and three subjects showing decreased performance
(21%, 9%, 33%). No significant associations existed
between the percent changes in plasma redox balance
markers and exercise performance.
Brachial artery blood flow
Resting and exercising BABF for the NAC and PLA con-
ditions are shown in Figure 3. Resting BABF was not dif-
ferent (P = 0.79) between NAC (99.3  31.1 mL/min)
and PLA (108.3  46.0 mL/min) conditions. In both
conditions, BABF significantly increased (F = 50.4,
P < 0.001) from resting values; however, there were no
differences (F = 0.74, P = 0.42) between NAC and PLA
during exercise. End-exercise BABF was not significantly
different (P = 0.29) between NAC (413  109 mL/min)
and PLA (445  147 mL/min). There was considerable
intersubject variability in end-exercise BABF with five of
eight subjects having lower end-exercise BABF with NAC
compared to PLA. However, overall there was no rela-
tionship (P = 0.11) between the absolute change in end-
exercise BABF and exercise performance with NAC. The
absolute change in BABF from rest to end-exercise was
not different (P = 0.49) between conditions. The end-
exercise blood flow (NAC: 390  106 mL/min; PLA:
364  44 mL/min; P = 0.60) and absolute change in
blood flow (NAC: 299  99 mL/min; PLA:
282  32 mL/min; P = 0.72) were not different between
NAC and PLA for the subjects (n = 5) demonstrating
improved exercise performance with NAC. Figure 4
shows brachial artery diameters at rest and during hand-
grip exercise for both conditions. Resting brachial artery
diameter was not significantly different (P = 0.52)
between NAC (4.2  0.6 mm) and PLA (4.2  0.8 mm).
Brachial artery diameter increased (F = 64.3, P < 0.001)
from rest to exercise, but there were no differences
(F = 0.39, P = 0.55) between NAC and PLA. The absolute
change in brachial artery diameters from rest to end-exer-
cise was not significantly different (P = 1.0) between
PLA NAC
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Figure 2. Time to exhaustion with NAC and PLA. Mean (open
circles) and individual (closed circles) time to exhaustion values for
NAC and PLA supplementation. There were no significant
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Figure 4. Mean brachial artery diameters for NAC and PLA during
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conditions. For the subjects (n = 5) who improved per-
formance with NAC, the end-exercise diameter (NAC:
4.3  0.4 mm; PLA: 4.3  0.4 mm; P = 1.00) and abso-
lute change in diameter (NAC: 0.4  0.1 mm; PLA:
0.5  0.1 mm; P = 0.31) were not different between
NAC and PLA. There were negative relationships between
the absolute change in preexercise GSH/GSSG (NAC
minus PLA) and the absolute change (NAC minus PLA)
in resting (r2 = 0.62; P = 0.02) and end-exercise diameter
(r2 = 0.80; P = 0.003) (Fig. 5). No other significant asso-
ciations were present between changes in diameter and
plasma redox balance markers. Brachial artery shear rate
increased (F = 51.6, P < 0.001) from rest to exercise for
NAC and PLA, but no differences (F = 0.11, P = 0.75)
occurred between groups. The absolute change in brachial
artery shear rate from rest to end-exercise was not differ-
ent (P = 0.89) between conditions. No significant associa-
tions existed between the changes in plasma redox
balance markers and blood flow or shear rate.
NIRS
The NIRS measurements, deoxy-[Hb + Mb], oxy-
[Hb + Mb], total-[Hb + Mb], and TOI, are shown at rest
and during handgrip exercise in Figure 6. Resting deoxy-
[Hb + Mb] was not different (P = 0.42) at rest between
NAC and PLA. Deoxy-[Hb + Mb] significantly increased
(F = 13.7, P < 0.001) during exercise for both NAC and
PLA, but no significant differences (F = 0.13, P = 0.73)
existed between conditions. There were no relationships
(P > 0.05) between the absolute change in end-exercise
deoxy-[Hb + Mb] and plasma redox balance markers.
Oxy-[Hb + Mb] was not different (F = 0.058, P = 0.82)
at rest or during exercise between NAC and PLA. At rest,
total-[Hb + Mb] was not significantly different (P = 0.70)
at rest between PLA and NAC. Total-[Hb + Mb]
increased (F = 12.2, P < 0.001) with exercise in both con-
ditions, but no differences (F = 0.47, P = 0.52) existed
between NAC and PLA. TOI was not different at rest or
during exercise between NAC and PLA (F = 0.028,
P = 0.87). The end-exercise deoxy-[Hb + Mb] (NAC:
49.3  2.0 lmol/L; PLA: 49.7  6.1 lmol/L; P = 0.91)
and total-[Hb + Mb] (NAC: 106.8  7.1 mL/min lmol/
L; PLA: 109.4  7.8 lmol/L; P = 0.64) were not different
between NAC and PLA for the subjects (n = 5) who
improved exercise performance with NAC.
Discussion
Major findings
The major findings of this study are that an acute oral
supplementation of NAC does not affect blood flow or
muscle oxygenation characteristics at rest or during sev-
ere-intensity handgrip exercise in healthy men. NAC sup-
plementation did lead to increases in preexercise plasma
CySH, tCyS, and CySH:tCyS. Lastly, handgrip exercise
performance was not improved with an acute dose of
NAC supplementation.
NAC supplementation
Previous studies have used both intravenous and oral
NAC supplementation to modify plasma redox balance
(Ferreira and Reid 2008). Recently, oral NAC ingestion
has been utilized because it is a more practical approach
for common usage because intravenous infusion is only
approved by the Food and Drug Administration for acet-
aminophen overdose treatment (Ferreira et al. 2011).
Chronic (3–9 days) and acute oral NAC supplementation
has been shown to alter plasma redox balance in healthy
subjects (Ferreira et al. 2011; Corn and Barstow 2011;
Matuszczak et al. 2005; Slattery et al. 2014); however, this
is not a consistent finding (Kelly et al. 2009; Trewin et al.
2013). Ferreira et al. (2011) recently reported that 70 mg/
kg was the highest oral acute dosage that could be well-
tolerated by subjects without adverse reactions. This
dosage has been reported to increase tGSH (Corn and
Barstow 2011) as well as increase CySH, tCyS, CySH:tCyS,
and decrease GSSG (Ferreira et al. 2011). The changes in
tGSH, CySH, tCys, and CySH:tCyS in this study are in
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Figure 5. Relationship between preexercise GSSG/GSH and end-
exercise diameter. The relationship between absolute changes in
preexercise GSSG/GSH (NAC minus PLA) and end-exercise diameter
(NAC minus PLA). There was a significant negative relationship
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agreement with these previous studies. Interestingly, we
observed an elevated GSSG with the acute NAC supple-
mentation, which is in contrast to the previous study
measuring GSSG following an acute oral NAC supple-
mentation (Ferreira et al. 2011). This discrepancy may be
due to differences in the method of delivery (capsule ver-
sus drinking solution).
NAC and peripheral hemodynamics
In health, neither intravenous infusion nor oral supple-
mentation of NAC has led to changes in resting blood
flow (Smith et al. 2014; Nyberg et al. 2012). Our results
are in agreement, and in addition show that resting mus-
cle oxygenation characteristics are not altered with NAC
supplementation in healthy men.
During strenuous exercise, the endogenous antioxidant
system is unable to completely buffer the oxidant concen-
tration leading to an accumulation of free radicals (Sen
1995). In regards to oxygen transport, free radicals and
thiol oxidation can decrease nitric oxide production
(Jaimes et al. 2001), negatively affect endothelial nitric
oxide synthase (Huang et al. 2001), and lead to increased
protein S-glutathionylation (Chen et al. 2010, 2011); how-
ever, it remains unknown if this occurs during severe-
intensity exercise in young men. Previous studies have
suggested that because NAC is an antioxidant and thiol
donor it may improve blood flow during fatiguing exercise
(Reid et al. 1994; Slattery et al. 2014; Reid 2015). In con-
trast, NAC infusion did not lead to increased plasma
nitrite concentrations during severe-intensity cycling exer-
cise in young men (Bailey et al. 2011). Furthermore, NAC
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infusion did not alter blood flow during moderate-inten-
sity exercise (Nyberg et al. 2012) despite reducing venous
GSSG in healthy men (Nyberg et al. 2014). Previous stud-
ies have shown that exercising blood flow is not different
(Richardson et al. 2007; Kirby et al. 2009) or decreased
(Copp et al. 2009) with antioxidant supplementation in
health. Our findings that NAC did not modify blood flow
or brachial artery vasodilation during severe-intensity
exercise are in agreement with these latter studies.
Although NAC led to increases in plasma CySH, it is pos-
sible that the men in this study had adequate endogenous
enzymatic and nonenzymatic antioxidant systems where
NAC supplementation did not lead to augmented free rad-
ical scavenging; however, without postexercise plasma
redox measurements this is unknown in this study. Inter-
estingly, we observed a negative relationship between the
absolute change in preexercise GSH/GSSG and the abso-
lute change in resting and end-exercise diameter between
conditions. This finding is supported by previous studies
showing an attenuated exercise-induced vasodilation
(Richardson et al. 2007) and vascular conductance (Copp
et al. 2009) with antioxidant supplementation in health;
however, further investigation of this finding is warranted
incorporating pre and postexercise redox balance markers.
An additional primary purpose of this study was to
determine if NAC affected muscle oxygenation character-
istics during severe-intensity exercise. We found that
NAC did not alter muscle oxygenation characteristics dur-
ing exercise. Recently, it has been shown that antioxidant
supplementation decreases the O2 delivery-O2 utilization
balance in rats (Copp et al. 2009). It is likely that a popu-
lation with greater oxidative stress may exhibit augmented
blood flow and vasodilation with NAC as seen with
antioxidant treatment with aging (Jablonski et al. 2007;
Kirby et al. 2009).
Exercise performance
Infusion and oral supplementation of NAC has been
reported to delay fatigue in both small muscle mass (Reid
et al. 1994; Supinski et al. 1997; Travaline et al. 1997;
Matuszczak et al. 2005; Kelly et al. 2009), and whole-body
exercise (Corn and Barstow 2011; Medved et al. 2004b;
McKenna et al. 2006; Slattery et al. 2014; Cobley et al.
2011). However, this is not a consistent finding in large
muscle mass exercise possibly due to the training status,
exercise intensity, and/or method of delivery (Medved
et al. 2003, 2004a; Bailey et al. 2011; Trewin et al. 2013).
In addition, it has been suggested that NAC supplementa-
tion may be most effective during submaximal exercise
(rather than maximal) (Matuszczak et al. 2005; Reid et al.
1994; Ferreira and Reid 2008) and with small muscle
mass exercise (Ferreira and Reid 2008). Unexpectedly, we
did not observe improvements in exercise performance in
small muscle mass exercise with NAC due to high inter-
subject variability. However, consistent with previous
studies (Bailey et al. 2011; Medved et al. 2004a), we
found a variable response with most subjects (5 of 8)
improving exercise performance with NAC supplementa-
tion. For whole-body exercise performance, NAC appears
to be more effective in endurance-trained subjects
(Medved et al. 2004a,b), but the role of training status
during small muscle mass exercise is unknown. Recently,
Ferreira et al. (2011) using the same dosage reported a
relationship between exercise performance and preexercise
CySH:tCyS levels. Interestingly, we did not observe any
relationships between preexercise plasma redox balance
values and exercise performance.
Limitations
Several limitations may have influenced our results. First,
the ultrasound used in this study does not allow for
simultaneous measurements of velocity and diameter.
Therefore, the timing of the image capture occurred dur-
ing diastole and one vessel diameter was used at each
time point to calculate blood flow (Ade et al. 2012; Brox-
terman et al. 2014; Smith et al. 2014). Second, postexer-
cise plasma redox balance measurements would have
provided valuable insight regarding the extent to which
NAC altered redox status during exercise compared to
PLA, as well as the adequacy of reactive oxygen species
scavenging during exercise.
Conclusion
In conclusion, we found that an acute oral supplementa-
tion of NAC did not modify the blood flow or vasodila-
tory response during severe-intensity small muscle mass
exercise. In addition, we did not observe differences in
muscle oxygenation characteristics at rest or during exer-
cise with NAC. Future studies should examine if blood
flow and vasodilation is improved with NAC in popula-
tions with greater oxidative stress.
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